A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)
Phase 3
Completed
- Conditions
- Asthma, Bronchial
- Registration Number
- NCT00489346
- Lead Sponsor
- Organon and Co
- Brief Summary
A study to evaluate MK0476 and Fluticasone to control asthma in patients with mild persistent asthma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 994
Inclusion Criteria
- Patient is male or female, 6-14 years of age with mild persistent asthma
- Patient has a history of the following symptoms: wheezing, chest tightness, cough, etc.
- Patient has asthma diagnosed by a doctor
Exclusion Criteria
- Patient is hospitalized
- Patient has had major surgery or participated in another clinical trial in the last 4 weeks
- Patient has been on a breathing tube for asthma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Improvement of asthma with MK0476 and Fluticasone as measured by number of asthma rescue-free days Duration of Trial
- Secondary Outcome Measures
Name Time Method Improved effect of MK0476 and fluticasone on FEV1 values Duration of Trial